The Cooper Companies, Inc

Healthcare · Medical Instruments & Supplies

56.90$ -0.9% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

The Cooper Companies, Inc (COO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 1,066 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement COO
Line item	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	927	932	943	1,003	1,018	965	1,002	1,060	1,065	1,024	1,082	1,066	4,237
Cost of Revenue	321	308	311	340	341	305	323	368	464	329	346	401	1,540
Gross Profit	607	624	631	663	678	660	679	692	601	695	735	665	2,697
Research & Development	37	40	39	39	38	41	46	45	41	44	43	42	170
Selling, General & Administrative	388	381	380	381	391	388	399	422	419	390	676	401	1,887
Total Operating Expenses	471	471	470	471	479	478	494	516	461	482	766	443	2,152
Operating Income	136	153	162	193	198	182	185	176	140	213	-31	222	545
Interest Expense	26	30	29	29	27	26	33	25	24	22	21	27	95
Pre-Tax Income	106	120	130	164	169	153	145	152	117	192	-48	202	462
Income Tax Expense	22	39	41	59	51	49	57	54	32	61	30	-231	-108
Net Income	85	81	89	105	118	104	88	98	85	131	-78	433	570
EBITDA	225	247	257	281	287	270	261	273	215	310	68	317	910

LTM = last twelve months (sum of the four most recent quarters).

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings